Renue By Science Liposomal NMN Review (2026)
Renue liposomal NMN costs $64.95 for 45 servings. We check batch testing, subscription terms and why the linked study does not establish Renue-specific benefit.
Updated
5 min read · 15 sources
On this page
Renue By Science sells liposomal NMN with unusually accessible batch testing, but its strongest purchase argument is the paperwork rather than its delivery claims. On October 15, 2026, its 90-capsule bottle was $64.95 one-time or $58.46 on subscription. The label supplies 500 mg per two capsules, making this 45 servings, not a 90-day supply. The important scientific distinction is equally concrete: the 84% NAD+ increase featured on its product page comes from a small published study of SINTO liposomal NMN, not a paper identifying Renue’s retail capsules as the tested product. 1112
What is in the bottle?
Featured partner
CoreAge Rx
From $93/mo
Check availabilityRead our reviewAffiliate link. We may earn a commission at no extra cost to you.
Affiliate partner
Embody
NAD+ injection or nasal spray, dosing protocol published
See EmbodyEach capsule supplies 250 mg NMN, with a two-capsule serving providing 500 mg. The disclosed inactive ingredients are hypromellose capsule, microcrystalline cellulose, sunflower lecithin and rice flour. At the labeled serving, the bottle works out to about $1.44 per day one-time or $1.30 per day on subscription. The purchase selector promises a 10% recurring discount and says buyers can cancel, skip or change frequency anytime. Check the selected delivery interval: 45 servings do not automatically mean a calendar-month shipment. 12
The page displays two shipping thresholds: over $45 within the subscription box and $50+ beneath the purchase button. This bottle exceeds both displayed thresholds before any discounts, but smaller orders need a final shipping check. Its separate refund policy offers support-assisted refunds or replacements for products purchased within the preceding 60 days. It does not spell out every return-shipping or opened-product condition; ask support before treating the policy as an unconditional trial. 13
For context on delivery formats, see our liposomal NAD+ evidence guide and sublingual NMN vs capsules.
Bottle and buying terms
| Detail | What buyers receive |
|---|---|
| NMN per serving | 500 mg across two capsules |
| Bottle duration | 90 capsules / 45 labeled servings |
| One-time purchase | $64.95; about $1.44 per serving |
| Subscription | $58.46; about $1.30 per serving |
| Refund window | Contact support within 60 days of purchase |
What the 84% study actually tested
Renue links a 2025 article by Kawakami, Maeda and Fukuzawa in Annals of Clinical and Medical Case Reports. It is a published comparison of liposomal NMN, ordinary NMN and placebo. Fifteen healthy men aged 40 or older were divided into three groups of five: placebo, ordinary NMN and liposomal NMN, with the active groups taking 350 mg daily for four weeks. The paper describes double blinding and reports a larger NAD+ response in the liposomal group. 11
The attribution is the catch: its methods identify SINTO liposomal NMN, supplied free by Premier Anti-Aging Co., Ltd. The report does not name Renue’s retail capsules as the intervention. Five men per group, a short biomarker study and a different named product cannot establish that a buyer will get the same result from Renue. Nor does blood NAD+ establish how much intact NMN reached tissues or demonstrate better energy, cognition or lifespan. 11
A human comparison therefore exists, but the claim that Renue’s specific liposomal product is clinically superior remains unestablished. Product equivalence requires evidence about the actual formulation, not the shared word “liposomal.”
How this fits the wider NMN evidence
Oral NMN has plausible biology, but intestinal handling is more complicated than a direct pipeline from a capsule to a cell. Work on enterohepatic circulation shows that NAD+ precursors can be broken down and rebuilt through intestinal and liver pathways 1. A rise in NAD+ therefore cannot, by itself, prove a seller’s proposed absorption mechanism.
Ordinary swallowed NMN raises blood NAD+ in human trials: the dose-ranging trial in healthy middle-aged adults 2, a controlled oral-NMN study 3, the pharmaceutical-grade MIB-626 trial 4 and a single-dose metabolism study 5. Those results matter because a buyer does not need to assume ordinary NMN is ineffective to consider the liposomal version.
Different molecules also cannot validate one another’s delivery systems. Human liposomal vitamin C research includes a scoping review 7 and a randomized crossover trial 8, but neither tested NMN or this Renue product. Formulation-specific clinical comparisons remain the relevant standard.
The downstream benefit question is separate. A 2025 NMN/NR meta-analysis found no reliable improvement in pooled muscle mass or function 9. Some smaller NMN studies report signals such as maintained walking speed or better sleep 10, while NR trials show that NAD+ can increase without establishing broad rejuvenation 6. Read does NMN actually work? for the outcome evidence beyond the blood test.
What the evidence establishes
- Ordinary oral NMN raises blood NAD+Moderate evidence
Supported across controlled human studies.
- Liposomal NMN comparative biomarker signalWeak evidence
Published study: 15 men, five per arm, SINTO product.
- Tested batch meets NMN potency specificationStrong evidence
Lot 062827351: 507.776 mg per two-capsule serving.
- Renue capsules outperform plain NMN clinicallyNone evidence
The linked trial identifies a different named formulation; clinical outcomes remain unproven.
The strongest reason to consider Renue: batch testing
Renue’s testing directory provides named batches rather than only a generic purity badge. For lot 062827351, the linked Summit Nutritional Laboratories potency report, dated July 20, 2026, reports 507.776 mg NMN per two-capsule serving against a specification above 500 mg. The report identifies the sample, lot and HPLC method and displays ISO/IEC 17025 accreditation information. This is useful evidence about the tested sample’s contents. 14
The directory separately links potency, heavy-metal and microbiology documents. Match your bottle’s lot to the relevant documents; the potency result alone does not establish every contaminant result, shelf life in your home or clinical benefit. Published batch access is nevertheless a concrete reason to consider this seller when comparing best NMN supplements. 15
Is Renue By Science worth it?
Renue is a reasonable option for buyers who want a liposomal capsule with public batch paperwork and understand the limits of its study attribution. The price is $64.95 for 45 labeled servings, and subscription savings bring that to $58.46. Compare those actual serving costs with alternatives rather than assuming a “premium” label means either superior value or superior absorption.
The principal drawback is that the product-page study does not identify the capsules being sold here as the tested intervention. A positive trial of another named liposomal NMN does not prove Renue outperforms plain NMN, and no NAD+ test result promises a noticeable wellness payoff. Choose it for its capsule format and verifiable batch contents if those features matter to you; the evidence does not justify expecting a proven rejuvenation advantage.
For alternatives, see best NAD+ supplements, the NAD+ therapy evidence pillar and the NAD+ rankings hub.
This is consumer education, not medical advice. NMN is a supplement, not an FDA-approved treatment. If you are pregnant, nursing, taking medication or managing a medical condition, discuss the full ingredient label with a clinician.
Frequently asked questions
How much does Renue liposomal NMN cost?
The October 15, 2026 product page displayed $64.95 one-time or $58.46 on subscription for 90 capsules. Each two-capsule serving supplies 500 mg NMN, so a bottle contains 45 servings: about $1.44 or $1.30 per day respectively.
Is the 84% NAD+ increase a Renue product trial?
The linked 2025 published paper tested SINTO liposomal NMN supplied by Premier Anti-Aging, not an intervention identified as Renue retail capsules. It included 15 men divided among liposomal NMN, ordinary NMN and placebo, with five in each arm. It supports a small comparative biomarker signal for that tested formulation, not proven Renue-specific superiority.
Is liposomal NMN better than regular NMN?
A small published comparison reported a greater NAD+ increase with SINTO liposomal NMN than ordinary NMN, but five participants per arm and a different named product limit what this establishes for Renue. Neither that biomarker result nor the liposomal label proves better energy, cognition or longevity.
Does Renue publish independent testing?
Yes. Its batch directory links potency and contaminant reports. The Summit Nutritional Laboratories potency report for lot 062827351 reports 507.776 mg NMN per two-capsule serving against a specification above 500 mg. Match the report to your own bottle’s lot; this is sample-specific chemistry evidence, not proof of benefit.
References
- Yaku K, Palikhe S, Iqbal T, et al. (2025). Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances. https://pubmed.ncbi.nlm.nih.gov/40117359/
- Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
- Okabe K, Yaku K, Uchida Y, et al. (2022). Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Frontiers in Nutrition. https://pubmed.ncbi.nlm.nih.gov/35479740/
- Pencina KM, Lavu S, Dos Santos M, et al. (2023). MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults. The Journals of Gerontology: Series A. https://pubmed.ncbi.nlm.nih.gov/35182418/
- Irie J, Inagaki E, Fujita M, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. https://pubmed.ncbi.nlm.nih.gov/31685720/
- Conze D, Brenner C, Kruger CL (2019). Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/31278280/
- Carr AC (2025). Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology. https://pubmed.ncbi.nlm.nih.gov/40506693/
- Purpura M, Jäger R, Godavarthi A, Bhaskarachar D, Tinsley GM (2024). Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. European Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/39237620/
- Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle. https://pubmed.ncbi.nlm.nih.gov/40275690/
- Morifuji M, Higashi S, Ebihara S, Nagata M (2024). Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience. https://pubmed.ncbi.nlm.nih.gov/38789831/
- Kawakami S, Maeda Y, Fukuzawa Y (2025). Intervention Study Comparing Blood NAD+ Concentrations with Liposomal and Non-Liposomal Nicotinamide Mononucleotide. Annals of Clinical and Medical Case Reports. https://acmcasereport.org/wp-content/uploads/2025/02/ACMCR-v14-2340-1.pdf
- Renue By Science (2026). Liposomal NMN capsule label and purchase terms. Renue By Science website.
- Renue By Science (2026). Refund policy. Renue By Science website.
- Summit Nutritional Laboratories (2026). Liposomal NMN potency report, lot 062827351, July 20, 2026. Summit Nutritional Laboratories. https://renuebyscience.com/cdn/shop/files/260709_038-02_Alive_By_Nature_656165996568_Nicotinamide_Mononucelotide_Liposomal_062827351.pdf?v=8959368093604994433
- Renue By Science (2026). Third-party testing directory. Renue By Science website.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Related reading
Wonderfeel Youngr NMN Review: Is 900mg Worth It?
Wonderfeel Youngr costs $73 on subscription or $88 one-time for 30 servings. We check all five active ingredients, renewal timing, testing and return limits.
ReadTru Niagen Review: NR Evidence, Price and Returns
Review Tru Niagen 300 mg pricing, return terms and ingredient trials. What higher NAD+ levels show—and why they do not establish an anti-aging benefit.
ReadIs NAD+ Therapy Worth It? An Evidence-Based Buyer Guide
What NAD+ studies show, how treatment costs compare, and the plan and refund terms to check before paying for IV therapy or injections.
ReadNAD+ and NR for Multiple Sclerosis: The NORSEMAN Study
What the NORSEMAN trial is testing in progressive MS, what its registry shows, and why oral NR research does not prove NAD+ injections work.
ReadNAD+ and Bipolar Disorder: What the NR Research Means
Why brain-energy research and a study at a bipolar center do not establish NAD+ treatment for bipolar disorder, mania prevention or mood stabilization.
ReadLiposomal NAD+: Does Oral Absorption Really Work?
Liposomal NAD+ is sold as an oral shortcut past the gut. We check what absorption data exists — and the bioavailability claims are mostly brand-made.
Read